Free Trial

PetVivo (PETV) Competitors

PetVivo logo
$0.78 -0.04 (-4.90%)
As of 03:51 PM Eastern

PETV vs. HYPR, NVNO, APYX, NTRB, VANI, CTSO, LUNG, TELA, RBOT, and SPAI

Should you be buying PetVivo stock or one of its competitors? The main competitors of PetVivo include Hyperfine (HYPR), enVVeno Medical (NVNO), Apyx Medical (APYX), Nutriband (NTRB), Vivani Medical (VANI), Cytosorbents (CTSO), Pulmonx (LUNG), TELA Bio (TELA), Vicarious Surgical (RBOT), and Safe Pro Group (SPAI). These companies are all part of the "medical equipment" industry.

PetVivo vs. Its Competitors

PetVivo (NASDAQ:PETV) and Hyperfine (NASDAQ:HYPR) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

24.5% of PetVivo shares are owned by institutional investors. Comparatively, 15.0% of Hyperfine shares are owned by institutional investors. 10.8% of PetVivo shares are owned by company insiders. Comparatively, 31.0% of Hyperfine shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Hyperfine has a net margin of -364.54% compared to PetVivo's net margin of -902.82%. Hyperfine's return on equity of -78.47% beat PetVivo's return on equity.

Company Net Margins Return on Equity Return on Assets
PetVivo-902.82% -4,813.07% -281.78%
Hyperfine -364.54%-78.47%-65.00%

Hyperfine has a consensus target price of $1.23, suggesting a potential downside of 15.40%. Given Hyperfine's stronger consensus rating and higher probable upside, analysts plainly believe Hyperfine is more favorable than PetVivo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PetVivo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Hyperfine
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

In the previous week, Hyperfine had 8 more articles in the media than PetVivo. MarketBeat recorded 10 mentions for Hyperfine and 2 mentions for PetVivo. Hyperfine's average media sentiment score of 0.39 beat PetVivo's score of 0.00 indicating that Hyperfine is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PetVivo
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Hyperfine
2 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

PetVivo has a beta of 0.66, suggesting that its stock price is 34% less volatile than the S&P 500. Comparatively, Hyperfine has a beta of 1.06, suggesting that its stock price is 6% more volatile than the S&P 500.

PetVivo has higher earnings, but lower revenue than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PetVivo$1.05M20.65-$10.95M-$0.42-1.87
Hyperfine$12.89M8.76-$40.72M-$0.54-2.69

Summary

Hyperfine beats PetVivo on 11 of the 16 factors compared between the two stocks.

Get PetVivo News Delivered to You Automatically

Sign up to receive the latest news and ratings for PETV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PETV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PETV vs. The Competition

MetricPetVivoSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$21.60M$78.71M$5.62B$9.84B
Dividend YieldN/AN/A4.61%4.07%
P/E Ratio-1.7410.2130.2925.74
Price / Sales20.6593.58463.41115.83
Price / CashN/A18.4138.2159.48
Price / Book-26.147.438.826.15
Net Income-$10.95M-$26.39M$3.25B$265.06M
7 Day Performance-8.53%3.24%4.05%2.80%
1 Month Performance5.42%4.82%4.32%1.68%
1 Year Performance39.53%48.94%36.25%29.59%

PetVivo Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PETV
PetVivo
N/A$0.78
-4.9%
N/A+68.3%$21.60M$1.05M-1.7420News Coverage
Gap Down
HYPR
Hyperfine
1.8669 of 5 stars
$1.20
-7.7%
$1.06
-11.7%
+21.0%$93.40M$12.89M-2.22190Trending News
Earnings Report
Analyst Forecast
NVNO
enVVeno Medical
0.8484 of 5 stars
$4.58
+1.3%
N/A-8.4%$88.17MN/A-3.8230
APYX
Apyx Medical
1.8419 of 5 stars
$2.24
+0.4%
N/A+113.6%$84.72M$48.10M-4.98270Earnings Report
NTRB
Nutriband
3.2538 of 5 stars
$6.80
-0.7%
$13.00
+91.2%
+13.7%$75.82M$2.14M-7.5610Short Interest ↓
VANI
Vivani Medical
2.6372 of 5 stars
$1.27
+0.8%
$4.00
+215.0%
+8.6%$75.24MN/A-2.9520News Coverage
Earnings Report
Gap Down
CTSO
Cytosorbents
2.1079 of 5 stars
$1.06
-11.7%
$5.50
+418.9%
+20.7%$66.53M$35.60M-6.24220News Coverage
Earnings Report
Gap Down
LUNG
Pulmonx
4.261 of 5 stars
$1.59
+2.6%
$7.66
+382.0%
-73.4%$64.79M$83.79M-1.11250
TELA
TELA Bio
2.736 of 5 stars
$1.60
-14.0%
$7.25
+353.1%
-52.6%$63.30M$69.30M-1.13120Earnings Report
Gap Up
RBOT
Vicarious Surgical
0.8054 of 5 stars
$10.31
+12.0%
$8.50
-17.5%
+52.0%$61.11MN/A-0.99210Trending News
Earnings Report
Analyst Forecast
SPAI
Safe Pro Group
0.8806 of 5 stars
$4.01
+3.9%
$8.00
+99.5%
N/A$60.83M$2.17M-4.9511Earnings Report

Related Companies and Tools


This page (NASDAQ:PETV) was last updated on 8/14/2025 by MarketBeat.com Staff
From Our Partners